Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › RotaTeq

RotaTeq

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of RotaTeq

13 trials tracked of RotaTeq: 12 in phase 3 or 4 and 5 with published results. The most-cited published study has 42 citations.

13Trials tracked
12Phase 3 & 4
0Recruiting
5With published results
Phase distribution
Phase 4 3 Phase 3 9 Phase 2 1
  1. Phase 3 Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029) Completed · 42 cited
  2. Phase 3 Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) Completed · 34 cited
  3. Phase 3 A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION) Completed · 18 cited
  4. Phase 3 Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010) Completed · 16 cited
  5. Phase 3 Immunogenicity and Safety of Concomitant and Non-Concomitant Administration of RotaTeq® (V260) and Inactivated Poliomyelitis Vaccine in Healthy Chinese Infants (V260-074) Completed · 4 cited
  6. Phase 4 Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules Completed
Show 7 more trials
  1. Phase 4 Immunogenicity and Safety of Concomitant Administration of RotaTeq™ (V260) and the Diphtheria, Tetanus, Pertussis and Inactivated Poliovirus Vaccine (DTP-IPV) in Healthy Japanese Infants (V260-060) Completed
  2. Phase 4 Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study Completed
  3. Phase 3 A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006) Completed
  4. Phase 3 Rotavirus Efficacy and Safety Trial (REST)(V260-006) Completed
  5. Phase 3 Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005) Completed
  6. Phase 3 RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016) Completed
  7. Phase 2 Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers Completed

Showing the 13 most-cited and recently-updated of 13 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this medication. Check back soon.